SCOPUS 정보 검색 플랫폼

Toxicologic Pathology

Volumn 30, Issue 1, 2002, Pages 157-159

Alternatives Models in Carcinogenicity Testing—A European Perspective

(3) Van Der Laan, Jan Willem a Silva Lima, Beatriz a Snodin, David b

a UNIVERSITY OF LISBON (Portugal)

b MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY (United Kingdom)

Author keywords

Carcinogenicity testing; human pharmaceuticals; transgenic animals

Indexed keywords

CARCINOGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER MODEL; CANCER RISK; CARCINOGEN TESTING; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DISEASE MODEL; EUROPE; EVALUATION; FEMALE; GENOTOXICITY; HAZARD; HEALTH CARE POLICY; MALE; MOUSE; NONHUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; STRAIN IDENTIFICATION; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, LABORATORY; ANIMALS, WILD; CARCINOGENICITY TESTS; DISEASE MODELS, ANIMAL; EUROPE; MICE; MICE, TRANSGENIC; RATS;

ANIMALIA; MUS MUSCULUS;

EID: 0036189725 PISSN: 01926233 EISSN: None Source Type: Journal
DOI: 10.1080/01926230252824879 Document Type: Article

Times cited : (8)

References (6)

1
- 84857385770
- CPMP/818/97;
- Committee on Proprietory Medicinal Products (CPMP) (1997). Position paper on the genotoxic and carcinogenic potential of phenolphthalein. CPMP/818/97; http://www.eudra.org/cmea.html
- (1997) Position paper on the genotoxic and carcinogenic potential of phenolphthalein

2
- 0034051919
- Rodent Carcinogenicity tests need be no longer than 18 months: An analysis based on 210 chemicals in the IARC monographs
- Davies TS, Lynch BS, Monro AM, Munro IC, Nestmann ER (2000). Rodent Carcinogenicity tests need be no longer than 18 months: An analysis based on 210 chemicals in the IARC monographs. Food Chem Tox 38: 219-235.
- (2000) Food Chem Tox , vol.38 , pp. 219-235
- Davies, T.S.¹ Lynch, B.S.² Monro, A.M.³ Munro, I.C.⁴ Nestmann, E.R.⁵

3
- 0342316476
- Human biological relevance and the use of threshold-argument s in regulatory genotoxicity assessment: Experience with pharmaceuticals
- Muller L., Kasper P. (2000). Human biological relevance and the use of threshold-argument s in regulatory genotoxicity assessment: Experience with pharmaceuticals. Mutation Res 464: 19-34.
- (2000) Mutation Res , vol.464 , pp. 19-34
- Muller, L.¹ Kasper, P.²

4
- 0033742687
- Mechanisms of nongenotoxic carcinogenesis and assessment of the human hazard
- Silva Lima B., Van der Laan JW (2000). Mechanisms of nongenotoxic carcinogenesis and assessment of the human hazard. Regul Toxicol Pharmacol 32: 135-143.
- (2000) Regul Toxicol Pharmacol , vol.32 , pp. 135-143
- Silva Lima, B.¹ Van der Laan, J.W.²

5
- 0027408818
- Stratification of rodent carcinogenicity bioassay results to reflect relative human hazard
- Tennant RW (1993). Stratification of rodent carcinogenicity bioassay results to reflect relative human hazard. Mutation Res 286: 111-118.
- (1993) Mutation Res , vol.286 , pp. 111-118
- Tennant, R.W.¹

6
- 0031080023
- Theutility of two rodent species in carcinogeni c risk assessment of pharmaceutical s in Europe
- Van Oosterhout, Jpj, Van der Laan JW, De Waal EJ, Olejniczak K., Hilgenfeld M., Schmidt V., Bass R. (1997). Theutility of two rodent species in carcinogeni c risk assessment of pharmaceutical s in Europe. Regul Toxicol Pharmacol 25: 6-17.
- (1997) Regul Toxicol Pharmacol , vol.25 , pp. 6-17
- Van Oosterhout, J.¹ Van der Laan, J.W.² De Waal, E.J.³ Olejniczak, K.⁴ Hilgenfeld, M.⁵ Schmidt, V.⁶ Bass, R.⁷

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.